Global Intravenous Immunoglobulin (IVIg) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Intravenous immunoglobulin (IVIg) is a treatment used in patients with severe antibody deficiency. Intravenous immunoglobulin (IVIg) is made from human plasma.

    The Asia Pacific market is expected to grow at the fastest rate during the forecast period due to the growth of the healthcare industry in countries such as China, India, and Japan. The global intravenous immunoglobulin (IVIG) market is projected to grow at a CAGR of 7% during the forecast period, 2020-2026.

    The factors such as the high prevalence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia coupled with the surge in geriatric population and rise in the number of hemophilic patients are driving the Intravenous Immunoglobulin (IVIg) market.

    Intravenous Immunoglobulin (IVIg) market report explains the definition, types, applications, major countries, and major players of the Intravenous Immunoglobulin (IVIg) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Biotest

    • CBPO

    • Shanghai RAAS

    • CNBG

    • Sichuan Yuanda Shuyang

    • Kedrion

    • Baxter

    • BPL

    • LFB Group

    • Hualan Bio

    • CSL

    • Grifols

    • Octapharma

    By Type:

    • IVIg Liquid

    • IVIg Powder

    By End-User:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Intravenous Immunoglobulin (IVIg) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Intravenous Immunoglobulin (IVIg) Outlook to 2028- Original Forecasts

    • 2.2 Intravenous Immunoglobulin (IVIg) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Intravenous Immunoglobulin (IVIg) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Intravenous Immunoglobulin (IVIg) Market- Recent Developments

    • 6.1 Intravenous Immunoglobulin (IVIg) Market News and Developments

    • 6.2 Intravenous Immunoglobulin (IVIg) Market Deals Landscape

    7 Intravenous Immunoglobulin (IVIg) Raw Materials and Cost Structure Analysis

    • 7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials

    • 7.2 Intravenous Immunoglobulin (IVIg) Price Trend of Key Raw Materials

    • 7.3 Intravenous Immunoglobulin (IVIg) Key Suppliers of Raw Materials

    • 7.4 Intravenous Immunoglobulin (IVIg) Market Concentration Rate of Raw Materials

    • 7.5 Intravenous Immunoglobulin (IVIg) Cost Structure Analysis

      • 7.5.1 Intravenous Immunoglobulin (IVIg) Raw Materials Analysis

      • 7.5.2 Intravenous Immunoglobulin (IVIg) Labor Cost Analysis

      • 7.5.3 Intravenous Immunoglobulin (IVIg) Manufacturing Expenses Analysis

    8 Global Intravenous Immunoglobulin (IVIg) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Intravenous Immunoglobulin (IVIg) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Intravenous Immunoglobulin (IVIg) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Intravenous Immunoglobulin (IVIg) Market Outlook by Types and Applications to 2022

    • 9.1 Global Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global IVIg Liquid Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global IVIg Powder Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Immunodeficiency Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Autoimmune Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Acute Infection Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Intravenous Immunoglobulin (IVIg) Market Analysis and Outlook till 2022

    • 10.1 Global Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.2.2 Canada Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.2.3 Mexico Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.2 UK Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.3 Spain Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.4 Belgium Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.5 France Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.6 Italy Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.7 Denmark Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.8 Finland Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.9 Norway Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.10 Sweden Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.11 Poland Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.12 Russia Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.3.13 Turkey Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.2 Japan Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.3 India Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.4 South Korea Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.5 Pakistan Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.6 Bangladesh Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.7 Indonesia Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.8 Thailand Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.9 Singapore Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.10 Malaysia Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.11 Philippines Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.4.12 Vietnam Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.2 Colombia Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.3 Chile Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.4 Argentina Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.5 Venezuela Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.6 Peru Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.5.8 Ecuador Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.6.2 Kuwait Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.6.3 Oman Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.6.4 Qatar Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.7.2 South Africa Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.7.3 Egypt Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.7.4 Algeria Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

      • 10.8.2 New Zealand Intravenous Immunoglobulin (IVIg) Consumption (2017-2022)

    11 Global Intravenous Immunoglobulin (IVIg) Competitive Analysis

    • 11.1 Biotest

      • 11.1.1 Biotest Company Details

      • 11.1.2 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Biotest Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.1.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 CBPO

      • 11.2.1 CBPO Company Details

      • 11.2.2 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 CBPO Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.2.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Shanghai RAAS

      • 11.3.1 Shanghai RAAS Company Details

      • 11.3.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.3.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 CNBG

      • 11.4.1 CNBG Company Details

      • 11.4.2 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 CNBG Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.4.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sichuan Yuanda Shuyang

      • 11.5.1 Sichuan Yuanda Shuyang Company Details

      • 11.5.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.5.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Kedrion

      • 11.6.1 Kedrion Company Details

      • 11.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Baxter

      • 11.7.1 Baxter Company Details

      • 11.7.2 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Baxter Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.7.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 BPL

      • 11.8.1 BPL Company Details

      • 11.8.2 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 BPL Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.8.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 LFB Group

      • 11.9.1 LFB Group Company Details

      • 11.9.2 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 LFB Group Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.9.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Hualan Bio

      • 11.10.1 Hualan Bio Company Details

      • 11.10.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.10.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 CSL

      • 11.11.1 CSL Company Details

      • 11.11.2 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 CSL Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.11.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Grifols

      • 11.12.1 Grifols Company Details

      • 11.12.2 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Grifols Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.12.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Octapharma

      • 11.13.1 Octapharma Company Details

      • 11.13.2 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Octapharma Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

      • 11.13.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Intravenous Immunoglobulin (IVIg) Market Outlook by Types and Applications to 2028

    • 12.1 Global Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global IVIg Liquid Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global IVIg Powder Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Acute Infection Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Intravenous Immunoglobulin (IVIg) Market Analysis and Outlook to 2028

    • 13.1 Global Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.2 UK Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.5 France Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.3 India Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Intravenous Immunoglobulin (IVIg) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Intravenous Immunoglobulin (IVIg)

    • Figure of Intravenous Immunoglobulin (IVIg) Picture

    • Table Global Intravenous Immunoglobulin (IVIg) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global IVIg Liquid Consumption and Growth Rate (2017-2022)

    • Figure Global IVIg Powder Consumption and Growth Rate (2017-2022)

    • Figure Global Immunodeficiency Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure United States Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Canada Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure Germany Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure UK Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Spain Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure France Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Italy Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Finland Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Norway Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Poland Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Russia Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table APAC Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure China Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Japan Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure India Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table South America Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Chile Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Peru Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table GCC Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure Bahrain Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Oman Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table Africa Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure Nigeria Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table Oceania Intravenous Immunoglobulin (IVIg) Consumption by Country (2017-2022)

    • Figure Australia Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Intravenous Immunoglobulin (IVIg) Consumption and Growth Rate (2017-2022)

    • Table Biotest Company Details

    • Table Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotest Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table CBPO Company Details

    • Table CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CBPO Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Shanghai RAAS Company Details

    • Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table CNBG Company Details

    • Table CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CNBG Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Sichuan Yuanda Shuyang Company Details

    • Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Kedrion Company Details

    • Table Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kedrion Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Baxter Company Details

    • Table Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table BPL Company Details

    • Table BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BPL Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table BPL Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table LFB Group Company Details

    • Table LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table LFB Group Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Hualan Bio Company Details

    • Table Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Bio Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table CSL Company Details

    • Table CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table CSL Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Grifols Company Details

    • Table Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Table Octapharma Company Details

    • Table Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Octapharma Intravenous Immunoglobulin (IVIg) Main Business and Markets Served

    • Table Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio

    • Figure Global IVIg Liquid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IVIg Powder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure United States Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure Germany Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2022-2028)

    • Figure Australia Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Intravenous Immunoglobulin (IVIg) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.